Sierra Capital LLC Biogen Inc. Transaction History

Sierra Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$187.54 - $223.02 $1,125 - $1,338	-6 Reduced 3.82%	151 $31,000
Q1 2022 May 03, 2022	SELL	$193.77 - $244.14 $1,550 - $1,953	-8 Reduced 4.85%	157 $33,000
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $3,134 - $4,028	14 Added 9.27%	165 $40,000
Q1 2021 May 28, 2021	BUY	$242.95 - $284.63 $36,685 - $42,979	151 New	151 $42,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Sierra Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Sierra Capital LLC with notifications on news.